These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8109847)

  • 41. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
    Tu Y; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
    Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
    Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
    [No Abstract]   [Full Text] [Related]  

  • 43. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
    Morris RE
    Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
    [No Abstract]   [Full Text] [Related]  

  • 44. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
    Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection.
    Wennberg L; Wallgren AC; Karlsson-Parra A; Kozlowski T; Sundberg B; Tibell A; Groth CG; Korsgren O
    Transplant Proc; 1995 Feb; 27(1):266-7. PubMed ID: 7533391
    [No Abstract]   [Full Text] [Related]  

  • 46. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
    Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
    Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapamycin's long-term effects on humoral and cellular immune responses in the rat.
    Daloze P; Chen H; Luo H; Xu D; Shan X; Wu J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):721-2. PubMed ID: 8438456
    [No Abstract]   [Full Text] [Related]  

  • 48. Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
    Blakely ML; Van der Werf WJ; Dalmasso AP; Bach FH
    Transplant Proc; 1994 Jun; 26(3):1374-5. PubMed ID: 8029946
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunosuppressive effects of leflunomide in a cardiac allograft model.
    Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy of rapamycin, RS-61443 and cyclophosphamide in the prolongation of survival of discordant pig to rabbit cardiac xenografts.
    Yatscoff RW; Wang S; Keenan R; Chackowsky P; Lowes N; Koshal A
    Can J Cardiol; 1994 Sep; 10(7):711-6. PubMed ID: 7922826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclosporin A, FK506, rapamycin: the use of a quantitative analytic tool to discriminate immunosuppressive drug interactions.
    Kahan BD
    J Am Soc Nephrol; 1992 Jun; 2(12 Suppl):S222-7. PubMed ID: 1379841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
    Robertson A; Plenter R; Francis DM; Clunie GJ
    Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
    [No Abstract]   [Full Text] [Related]  

  • 54. Additive immunosuppressive effect of combined mycophenolate mofetil and cyclosporin A in experimental rat cardiac transplantation.
    Ostraat O; Qi Z; Olausson M; Gannedahl G; Tufveson G; Ekberg H
    Transplant Proc; 1995 Dec; 27(6):3540. PubMed ID: 8540091
    [No Abstract]   [Full Text] [Related]  

  • 55. Induction of long-term graft tolerance and donor/recipient chimerism.
    Fisher RA; Cohen DS; Ben-Ezra JM; Sallade RE; Tawes JW; Tarry WC
    J Surg Res; 1996 Jan; 60(1):181-5. PubMed ID: 8592412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 57. SK&F 105685 treatment induces suppressor cell activity and modulates cell adhesion properties in rat recipients of cardiac allografts.
    Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):758-60. PubMed ID: 8094912
    [No Abstract]   [Full Text] [Related]  

  • 58. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts.
    Asano T; Murai M; Nakamura H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):761-2. PubMed ID: 8438471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
    Markus PM; Cai X; Selvaggi G; Cooper M; Harnaha J; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3232-3. PubMed ID: 1721418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.